Nautilus Biotechnology, Inc.
NAUT
$2.51
$0.041.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.67% | 17.46% | 16.53% | 11.30% | -3.35% |
| Total Depreciation and Amortization | -2.99% | 0.43% | 2.25% | 2.14% | 2.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.94% | -51.65% | -50.72% | -31.15% | 32.68% |
| Change in Net Operating Assets | 5.53% | 63.65% | 24.74% | 61.34% | -74.78% |
| Cash from Operations | 13.52% | 15.85% | 13.63% | 14.32% | -2.94% |
| Capital Expenditure | 75.94% | 41.04% | 22.66% | 66.15% | -145.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -97.30% | 112.81% | 0.43% | -14.22% | 193.78% |
| Cash from Investing | -97.88% | 106.02% | 1.26% | -12.71% | 190.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -77.05% | -100.00% | -70.22% | -92.65% | 73.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -77.05% | -100.00% | -70.22% | -92.65% | 73.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -149.43% | 48.32% | 244.43% | -11.69% | 142.48% |